TB4-Frag (TBF) Research Guide

Full name: Thymosin Beta-4 Fragment

An active fragment of Thymosin Beta-4 (TB-500) containing the key actin-binding domain responsible for tissue repair signaling. Smaller molecular size may improve tissue penetration while retaining the healing properties of the full-length peptide.

How TB4-Frag (TBF) Works

Retains the actin-sequestering motif of full TB-4, promoting cell migration, angiogenesis, and reduction of inflammation at injury sites. The shorter sequence may offer improved bioavailability and targeted tissue penetration.

Dosing Protocol

• Typical dose: 200-750 mcg per dose
• Frequency: Daily or every other day
• Duration: 4-8 weeks
• Route: Subcutaneous injection

Reported Benefits

• Wound and tissue healing
• Reduced inflammation
• Potential improved tissue penetration vs full TB-4
• Support for tendon and muscle repair
• Angiogenesis promotion

Potential Side Effects

• Injection site irritation
• Mild headache (rare)
• Fatigue (transient)

Research Citations

1. Active domain mapping of Thymosin Beta-4 (2018) - The central actin-binding domain (Ac-SDKP and LKKTET motifs) retains the majority of TB4 healing activity.

Related Healing & Recovery Compounds

• BPC-157 - Full Profile
• TB-500 - Full Profile
• Pentosan Polysulfate - Full Profile
• KPV - Full Profile
• Thymosin Beta-4 - Full Profile
• LL-37 - Full Profile

View full TB4-Frag (TBF) profile with 3D molecule viewer →